TRIS-Based Amphiphiles for Membrane Protein Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing amphipathic molecules used for extracting and stabilizing membrane proteins often denature or aggregate them, limiting research on membrane protein functions and structures due to their simple chemical structures, and existing glucoside-based molecules lack sufficient stabilization efficiency.
Innovation Solution
Development of a novel amphipathic compound with a glucoside as a hydrophilic group, specifically TRIS- or neopentyl glycol-derived triglucosides, which connect three saccharides in parallel to minimize protein-molecule complexes, optimizing hydrophile-lipophile balance and using amide or ether linkages for enhanced stability and fluidity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional amphipathic molecules (OG, NG, DM, DDM, LDAO) are used to extract and solubilize membrane proteins, then the proteins can be transferred to aqueous solution, but the proteins are easily denatured or agglomerated and rapidly lose their functions
Solution Approach 1:
The patent applies composite materials by combining multiple saccharide units (three glucose molecules) with a central core structure to create a complex amphipathic molecule. This composite structure provides both the solubilization capability needed for membrane protein extraction and the structural complexity required to maintain protein stability and prevent denaturation, thereby resolving the contradiction between reliability and adaptability.
Solution Approach 2:
The patent changes the molecular parameters of amphipathic molecules by increasing the saccharide content from one (in conventional molecules like OG and NG) to three saccharide units in the novel compounds. This parameter change enhances the hydrophilic character and molecular complexity, improving protein stability while maintaining solubilization efficiency.
2Reliability
If glucoside-based amphipathic molecules are used for membrane protein crystallization, then extraction can be achieved, but stabilization efficiency is insufficient
Solution Approach 1:
The patent employs composite materials by creating amphipathic molecules with three glucose units attached to a central core, forming a tripod-like structure. This composite design enhances stabilization efficiency for membrane protein crystallization while the systematic molecular architecture avoids excessive complexity, balancing reliability and device complexity.
3Adaptability or versatility
If existing amphipathic molecules with simple structures are used, then ease of manufacture is maintained, but they cannot sufficiently exhibit various characteristics of membrane proteins
Solution Approach 1:
The patent uses composite materials with three saccharide units to create amphipathic molecules that can sufficiently exhibit various characteristics of membrane proteins. The composite structure provides multiple interaction sites and enhanced structural diversity, enabling better representation of membrane protein characteristics while maintaining reasonable molecular complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel compounds provide superior membrane protein stabilization and crystallization capabilities, maintaining structural fluidity and stability, even with small hydrophilic groups, outperforming conventional amphipathic molecules like DDM and maltose-neopentyl glycol amphiphiles.
Implementation Method 1
an amphipathic molecule is necessary to extract the membrane proteins from a lipidic environment and solubilize and stabilize the same in an aqueous solution
Implementation Method 2
These bio-macromolecules include hydrophilic and hydrophobic portions, and thus, an amphipathic molecule is necessary
Data Source
AI summary
The present invention relates to a TRIS- or neopentyl glycol-based amphipathic compound, a method of preparing the same, and a method of extracting, solubilizing, stabilizing, or crystallizing a membrane protein using the same. By using the TRIS- or neopentyl glycol-based compound according to the present invention, a superior membrane protein solubilization effect is exhibited, a membrane protein can be stably stored for a long time in an aqueous solution, and the structural fluidity of the membrane protein can be excellently maintained. Accordingly, the TRIS- or neopentyl glycol-based compound can be utilized in analyzing functions and structures of membrane proteins. Membrane protein structure and function analysis is currently one of the most attractive fields of research in biology and chemistry. Since more than half of the new drugs under development target membrane proteins, the compound can be applied to membrane protein structure research closely related to drug discovery.